Hans Fredrik Bergström

Title: The Innovations of Hans Fredrik Bergström

Introduction

Hans Fredrik Bergström is a notable inventor based in Gothenburg, Sweden. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that may serve as therapeutic agents. His work focuses on addressing critical health issues, including heart failure and chronic kidney disease.

Latest Patents

Bergström holds a patent for "Compounds and their use," which generally relates to compounds of Formula (I) and pharmaceutically acceptable salts thereof. These compounds are identified as modulators of RXFP1 and may be useful in treating or preventing various diseases and conditions, such as heart failure with different ejection fractions, chronic kidney disease, and acute kidney injury. The patent also discusses compositions comprising these compounds, intermediates useful in their preparation, and processes for synthesizing these compounds.

Career Highlights

Throughout his career, Hans Fredrik Bergström has worked with prominent companies in the pharmaceutical industry, including AstraZeneca AB and Mitsubishi Tanabe Pharma Corporation. His experience in these organizations has allowed him to contribute to significant advancements in drug development and therapeutic solutions.

Collaborations

Bergström has collaborated with esteemed colleagues, including Kenneth Lars Granberg and Shigeki Sakamaki. These partnerships have further enhanced his research and innovation efforts in the pharmaceutical sector.

Conclusion

Hans Fredrik Bergström's contributions to the field of pharmaceuticals through his innovative compounds and collaborations highlight his importance as an inventor. His work continues to pave the way for advancements in treating critical health conditions.